Free tools Windows power users keep installed
One-click scans. No signup required.
The stock behind the “under-the-radar AI” prediction is Synopsys (NASDAQ: SNPS), a company whose electronic design automation (EDA) tools and semiconductor IP are used to design chips. Its long-term case rests on rising demand for complex computing systems, application-optimized silicon IP, and a broader engineering portfolio that now includes Ansys. Those trends could support growth, but neither company targets nor a major customer agreement can establish how SNPS will perform over the next decade.
Why Synopsys is part of the AI investment conversation
Synopsys has long sold EDA software used to design and test chips. The investment thesis is that AI and other demanding applications may increase the need for computing power and make electronic systems more complex. That could mean more demand for chip-design tools, semiconductor IP, simulation, and engineering software.
As an Amazon Associate I earn from qualifying purchases.
The company is also positioning itself across a wider span of the design process. Its integration of Ansys adds engineering simulation and system-level testing capabilities to its silicon-design portfolio. The strategic argument is that customers building increasingly complex systems may benefit from coordinating silicon design with broader engineering work.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Synopsys CEO and President Sassine Ghazi described the opportunity at the company’s September 30, 2026 Investor Day: “AI is creating multiple, reinforcing growth engines for Synopsys. The acceleration of frontier intelligence is fueling an unprecedented demand for compute power while increasing system complexity. Simultaneously, purpose-built silicon is reshaping the IP market, while Physical AI and agentic workflows are driving deeper integration of our trusted tools. Together, these forces are expanding our addressable market, increasing consumption of our technology, and creating new, recurring revenue streams.” This is management’s view of the company’s opportunity, not independent evidence that demand or revenue will grow at a particular rate.
#1 Best Overall
What the Amazon agreement does—and does not—show
On September 30, 2026, Synopsys and Amazon announced a multi-year agreement valued at more than $1 billion. Amazon is the lead customer for expanded application-optimized silicon IP. The announced collaboration also covers Synopsys EDA, simulation and analysis, AI-powered engineering, and cloud collaboration. Synopsys said it will use AWS services, including EC2 and Bedrock, in its own development work, and the companies plan to work on multiphysics solutions for Amazon Trainium and Graviton chips. (Synopsys announcement)
The agreement is a concrete example of customer collaboration around custom silicon and engineering. Its announced value is not the same as $1 billion of immediate revenue: the announcement describes a multi-year agreement and does not say that the full amount will be recognized at once.
Amazon SVP of foundational AI, custom silicon, and quantum computing Peter DeSantis said: “From Graviton to Trainium, purpose-built chips deliver better performance at lower cost because they’re designed for exactly what customers need.” That is Amazon’s stated rationale for custom chips, not a guarantee that every purpose-built chip will outperform alternatives or reduce costs.
What Synopsys management is targeting through FY2030
At its September 30, 2026 Investor Day, Synopsys set the following long-term objectives for FY2026–FY2030. These are management projections, not results already achieved. The company labels the financial targets below as non-GAAP where indicated and warns that they are forward-looking. (Synopsys Investor Day release)
| Measure | Synopsys objective or outlook | Period and qualification |
|---|---|---|
| Revenue growth | Approximately 15% | FY2026–FY2030 objective |
| Operating margin | Approximately 50% non-GAAP | FY2030 objective |
| EPS growth | Mid-20% range, non-GAAP | FY2026–FY2030 objective |
| Free-cash-flow growth | Mid-20% range, non-GAAP | FY2026–FY2030 objective |
| Revenue | Approximately $11.15 billion at the midpoint of guidance | FY2027 guidance range: $11.1 billion to $11.2 billion |
| Free cash flow | Approximately $3.1 billion | FY2027 company target |
Synopsys says it cannot reconcile several FY2028–FY2030 non-GAAP projections to comparable GAAP measures without unreasonable effort, citing the variability and limited predictability of adjustments excluded from those measures. Investors should therefore read the targets as management’s planning framework, not as a promise of GAAP earnings or cash flow.
What the decade-long prediction can—and cannot—tell you
The Motley Fool article by Lee Samaha, published October 5, 2026, argues that Synopsys could benefit as AI, physical AI, and other complex systems increase demand for computing and design tools. It also reports that Deutsche Bank maintained a buy rating and raised its price target from $590 to $640 after the Investor Day. That is an analyst target reported by the article, not a Synopsys forecast or a guarantee of future returns.
Samaha also presents rough 2030 valuation calculations, including estimated earnings and free cash flow and implied price-to-earnings and price-to-free-cash-flow multiples. Those are the author’s extrapolations, not company guidance. The article’s displayed 2030 EPS figure has an apparent unit issue that cannot be resolved from the cited company materials; Synopsys reported FY2027 non-GAAP EPS guidance of $19.04–$19.12 and said it could not fully reconcile projected FY2028–FY2030 EPS without unreasonable effort. The 2030 EPS estimate and multiples should not be treated as reliable valuation inputs without resolving that discrepancy.
Most importantly, no cited source establishes the probability that SNPS will outperform over the next decade. A credible growth thesis is not the same thing as a dependable stock-return prediction.
Best Value
Risks that could weaken the thesis
- Adoption may disappoint. The growth case depends on new end markets and technologies becoming widely adopted; progress may be slower or less extensive than management expects.
- Targets are not outcomes. Revenue growth, margins, and cash-flow goals depend on execution and remain forward-looking projections.
- Commercial value is not the same as recognized revenue. The Amazon agreement is multi-year, and its headline value does not establish the timing or amount of revenue in any particular period.
- Valuation arithmetic is assumption-sensitive. Long-range estimates can change sharply when assumptions about growth, cash flow, share count, or valuation multiples change. The apparent EPS-unit issue in the article adds another reason not to rely on its 2030 multiples as stated.
How to assess SNPS as an investor
Rather than treating “will it soar?” as a yes-or-no forecast, use the thesis as a set of claims to monitor:
Quick Recap
- Separate operating evidence from projections. Compare reported results with management’s FY2026–FY2030 objectives, keeping the non-GAAP measures distinct from GAAP results.
- Watch whether new opportunities translate into business. Track evidence that application-optimized IP, engineering simulation, and AI-related workflows are being adopted, rather than assuming that announcements alone establish recurring growth.
- Look for execution across the broader portfolio. The silicon-to-systems strategy depends on combining design, IP, and engineering capabilities effectively.
- Make your own valuation assumptions. Do not rely on the article’s 2030 multiples until the EPS-unit discrepancy is resolved; test how different growth and valuation assumptions affect your conclusion.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
